Académique Documents
Professionnel Documents
Culture Documents
Product Code : AB020 DAR No. : 365 95 23 Mfg. License No.: 288 & 492 Page 1 of 17
BMR Issued by : Mfg Date: Starting Date: Approved for start of Batch Manufacturing
1. Introduction:
1.1. General Description:
Each Aphrin 500 Capsule contains Cephradine Anhydrous Compacted Eq.to 500 mg Cephradine BP.
Technical Description
3. Process Details:
Total process for preparing Texit 200 Capsule is subdivided into Six (6) stages. BMR will cover Stage 1, 2, 3, & 4, BPR will cover Stage 5 & 6.
BPR consists of two (2) parts. BPR Part 1 will cover Stage 5; BPR Part 2 will cover Stage 6.
Temperature and Relative Humidity Record
Limit: Temperature between 15-25C and Relative Humidity within 40-50%
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
Note: Room temperature & Relative Humidity [RH] should be checked at the start of each stage and every 2 hours intervals. Checked By
(PE):_________________
Instruction:
Check the following in the AIRLOCK before dispensing (Put to fill up).
Checked by:
Checked by (PE): Checked by (QAE):
(Warehouse Personnel):
1. Dispensing
Removal of all extraneous materials, equipment and documents related to previous product/batch from the room.
Cleanliness of the room/ utensils/ accessories, if this is the first batch following a product change, remove the CLEANED label from the Room/equipment and include in the batch
wallet. record the following:
Name of the
Equipment ID Previous Product Batch No. Checked by
Equipment
Electronic Balance
Electronic Balance
Verify that the balances to be used are within their calibration period. Record the following:
Next Calibration
Equipment ID Name of the Balance Calibration Date Checked by
Date
Electronic Balance
Electronic Balance
READY FOR DISPENSING
Signature of
Starting Date: Starting time (AM/PM):
Production Executive:
1. Dispense the following items as per SOP and fill up the following table accordingly :
Instruction:
1. Follow calculation 1 when active is taken from a single Q.C. Ref. number.
2. Follow calculation 2 when active is taken from different Q.C. Ref. number.
Sl
No Calculation Remarks
.
1. When Cephradine Anhydrous(Compacted) is used from single potency:
= 50.00 Kg X 100
Potency
Qty. of Cephradine (Compacted) used from batch (Batch B) = (X) - (Y) X Potency (%) of Batch -A
Potency (%) of Batch -B
= Kg.
= Kg.
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
Calculated and Written By Checked By (QA Executive): Verified By (Production in Charge): Verified By (QA in Charge):
(Production Executive): sign and sign and sign sign and
date date and date date
Precautions: 1. Remove all materials of the previous product before start of manufacturing.
2. Check cleanliness and dryness of all equipment and utensils before start processing.
3. Use facemask, hand gloves and protective dresses.
4. Check labels of the materials before using.
5. Ensure the integrity of the sieves before and after sieving.
6. Ensure that the line clearance checklist and CLEANED TAG are signed by PE and QAE.
Equipment Used ID No. Previous Product Batch No. Cleanliness Checked by (QAE)
Sifter N/ A
Drum Blender 02-096-001 Sign & Date
40 mesh SS screen N/ A
Log books completed and area labeled: Signature and date (PE):
Sieving & Blending: Inform PE and QAE to check the following materials for correctness:
Cephradine Anhydrous Kg
Purified Talc 0.200 Kg
Magnesium Stearate 0.200 kg
2.2.2 Close the blender with lid and then lock the lid. Mix the total contents for 30 min.
Mixing Started ________am/pm; Mixing Finished ________am/pm; Done by (PO) _______________________ Checked by (PE) _______________
REMARKS IF ANY:
Note: In case of any deviations, it should be authorized by Quality Assurance. In case if any extraneous matter is observed on the materials, it should be immediately informed to the
Production Executive.
2.2.3 Inform QA (IPC) to draw the sample from the blender for analysis. QA (IPC) will check the Loss on Drying (LOD). Limit of LOD is NMT 7.00%.
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
Record the ID No. and Calibration information of used IPC instruments in the BMR.
Equipment Name Equipment ID No. Calibration Expiry
Moisture Analyser
Sampled by: _________ Time: _______am/pm Date: ___________ Loss on Drying (LOD) __________% Done by (IPC) ___________ Checked by (QAE) __________
2.2.4 Discharge the content of the blender into tarred double polylined plastic drums. Record the net weight and labeled the drums inside-outside correctly with PRODUCT
STATUS LABEL. Seal the drums keeping silica gel bags in between the polybag. Store the drum(s) in the intermediate bulk store awaiting Encapsulation on QA
Approval.
ID No. of the Balance: ____________________ Weighed By (PO): ______________ Checked By (PE/QAE): _______________
2.2.5 Reconciliation:
Theoretical weight of the Blended Materials (A) = Kg
[A - (B C)] X 100
Unaccountable Loss = _________% Limit: + 2.00% Done by (TL):_____________ Checked by (PE):_____________ Checked by
A
(QAE):______________
REMARKS IF ANY:
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
1.1 Stage 3:
Encapsulation:
Precautions:
LOG BOOKS COMPLETED AND AREA LABELLED: SIGNATURE AND DATE (PE):
2.3.1 Check the blended materials are available as per BMR. Checked by (PE): _________________ Checked by (QAE): _________________
2.3.2 Check the Capsule Shell size, Temperature and %RH before starting the encapsulation and make relavent entry into the log books.
2.3.3 Weigh the blended material into SS Plate, feed to the tray manually. Adjust fill weight; check Individual fill weight, average fill weight standard physical parameters as
given in the INITIAL PARAMETER CHECKING RECORD. Inform Production Executive (PE) to check the initial parameters.
Done by
Sl. No. Parameter Standards Result Checked By (PE)
(PO)
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
2 Individual fill weight (mg) (___________ to __________) mg [Theor. Fill wt. 7.5%]
Done by
Sl. No. Parameter Standards Result Checked By (PE)
(PO)
2 Individual fill weight (mg) (___________ to __________) mg [Theor. Fill wt. 7.5%]
2.3.4 Inform QA to collect initial sample. QA will record the results in In Process Checking Record by QA (Doc. No.: IPC/M/FP132-01). After getting QA approval, run the
machine.
2.3.5 In Process Appearance, weight and locking Check record of Capsule (By Production)
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
Wt. of Wt. of
Checke
10 Appearenc Lockin Checked 10 Appearenc Lockin
Date Time Date Time d Specification
Capsule e g By (PO) Capsule e g
By (PO)
(g) (g)
Appearance: Size#0, Pink opaque
body, Deep blue opaque cap, containing
off white color compacted powder.
(_____________ to _____________) mg
[(Theor. Fill wt. 7.5%) + EHGC wt.)]
Remarks:
Checked by (PE):
________________
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
Wt. of Wt. of
Checke
10 Appearenc Lockin Checked 10 Appearenc Lockin
Date Time Date Time d Specification
Capsule e g By (PO) Capsule e g
By (PO)
(g) (g)
Appearance: Size#0, Pink opaque
body, Deep blue opaque cap, containing
off white color compacted powder.
(_____________ to _____________) mg
[(Theor. Fill wt. 7.5%) + EHGC wt.)]
Remarks:
Checked by (PE):
________________
Remarks:
REMARKS IF ANY:
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
2.3.6 After Encapsulation, collect capsules into tarred double polylined plastic drums with proper label inside & outside of the drum and transfer to the WIP room for the
next stage polishing and checking.
1.2 Stage 4: Capsule Polishing & Checking: Capsule polishing is the step of removal of dust powder from the capsule shell after encapsulation by a capsule polishing
machine or manually with towel if machine not available and checking operation is done by visual checking of defective capsule during encapsulation & polishing. Polished
& checked capsule collect into tarred double polylined plastic drums with proper label.
Previous Product: Batch No.: Area Cleanliness Checked By (QAE):
Precautions:
1. Remove all materials of the previous product before start of manufacturing.
2. Check cleanliness and dryness of all equipment and utensils before start processing.
3. Use facemask, hand gloves and protective dresses. Avoid dust and inhalation of powder.
4. Check labels of the materials before using.
5. Ensure that the line clearance checklist and CLEANED TAG are signed by PP and QAE.
Cleanliness Cleanliness
Equipment Used ID No. Previous Product Batch No. Checked By (PE) Checked By
(QAE)
Capsule polishing machine
S S perforated bowl N/A
Dust Collector N/A
Cleaned Towel dedicated for
N/A
Aphrin
2.4.1 Storage: Label each drum inside outside correctly. Seal the drums keeping silica gel bags in between polythene bags and store the drums in the WIP room awaiting
blistering on QA Approval.
2.4.2 Reconciliation:
Theoretical Qty. of the Capsule (A) = _____________________ Pcs (From step 2.2.4)
Actual Qty. of the Capsule (B) = _____________________ pcs (Total wt. of filled Capsule divied by Net average wt. of Capsule)
IPC Sample (C) = _____________________ pcs
In process rejects (D) = _____________________ pcs
REMARKS IF ANY:
VERITAS PHARMACEUTICALS LTD
TOLL MANUFACTURING AT APEX PHARMACEUTICALS LTD.
[A - (B C D)] X 100
Unaccountable Loss = __________ __% Limit: + 2.00% Done by (TL):______________ Checked by (PE):_____________
A
3.0 Job Allocation Data Sheet
DATE OPERATION FROM TO OPERATOR ID No. TOTAL MAN HOUR CHECKED BY (TL/PE)
Dispensing
Seiving and
Blending
Encapsulation
Polishing &
Checking
4.0 Note any Deviation, OOS (Valid/Invalid), Change Request regarding the BMR
Production Approval:
_______________
7.0 QA Comments
QA Approval: _______________